RPAM
Rhenman & Partners Asset Management Portfolio holdings
AUM
$791M
This Quarter Return
+9.05%
1 Year Return
+12.81%
3 Year Return
+98.32%
5 Year Return
+175.58%
10 Year Return
+579.5%
AUM
$661M
AUM Growth
+$661M
(+5.4%)
Cap. Flow
-$9.85M
Cap. Flow
% of AUM
-1.49%
Top 10 Holdings %
Top 10 Hldgs %
25.72%
Holding
101
New
10
Increased
24
Reduced
44
Closed
5
Top Buys
| 1 |
ABMD
Abiomed Inc
ABMD
|
$13M |
| 2 |
Perrigo
PRGO
|
$11.6M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
$11.2M |
| 4 |
CVS Health
CVS
|
$8.12M |
| 5 |
Bausch Health
BHC
|
$7.01M |
Top Sells
| 1 |
Amgen
AMGN
|
$8.6M |
| 2 |
Alkermes
ALKS
|
$7.7M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$6.17M |
| 4 |
Edwards Lifesciences
EW
|
$5.92M |
| 5 |
HCA Healthcare
HCA
|
$5.68M |
Sector Composition
| 1 | Healthcare | 92.69% |
| 2 | Financials | 1.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Cooper Companies
COO
$13.3B
| $4.97M | 0.75% |
37,000
+4,000
| +12% | +$537K |
|
|
CERN
52
DELISTED
Cerner Corp
CERN
| $4.93M | 0.75% |
82,000
-34,000
| -29% | -$2.05M |
|
53
Cencora
COR
$57.2B
| $4.77M | 0.72% |
46,000
-17,000
| -27% | -$1.76M |
|
54
Iovance Biotherapeutics
IOVA
$800M
| $4.44M | 0.67% |
575,000
-108,108
| -16% | -$835K |
|
55
Acadia Pharmaceuticals
ACAD
$4.34B
| $4.28M | 0.65% |
120,000
-76,000
| -39% | -$2.71M |
|
|
ELGX
56
DELISTED
Endologix Inc
ELGX
| $4.16M | 0.63% |
420,000
+191,000
| +83% | +$1.89M |
|
57
Ionis Pharmaceuticals
IONS
$9.64B
| $4.15M | 0.63% |
67,000
-13,000
| -16% | -$805K |
|
58
LivaNova
LIVN
$3.09B
| $3.92M | 0.59% |
+66,000
| New | +$3.92M |
|
|
ICPT
59
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $3.88M | 0.59% |
26,000
-6,000
| -19% | -$896K |
|
60
Supernus Pharmaceuticals
SUPN
$2.52B
| $3.87M | 0.59% |
288,000
-65,328
| -18% | -$878K |
|
|
61
Edwards Lifesciences
EW
$47.7B
| $3.87M | 0.59% |
49,000
-13,000
| -21% | -$5.92M |
|
|
ZLTQ
62
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
| $3.65M | 0.55% |
128,000
-29,000
| -18% | -$827K |
|
63
Insulet
PODD
$24.2B
| $3.63M | 0.55% |
96,000
-14,000
| -13% | -$529K |
|
|
BXLT
64
DELISTED
BAXALTA INC COM STK (DE)
BXLT
| $3.44M | 0.52% |
+88,000
| New | +$3.44M |
|
|
HTWR
65
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
| $3.38M | 0.51% |
67,000
-20,000
| -23% | -$1.01M |
|
|
PTLA
66
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $3.19M | 0.48% |
62,000
-9,000
| -13% | -$463K |
|
|
HZNP
67
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $3.16M | 0.48% |
+146,000
| New | +$3.16M |
|
68
MacroGenics
MGNX
$121M
| $2.91M | 0.44% |
94,000
-13,959
| -13% | -$432K |
|
|
ACHN
69
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $2.87M | 0.43% |
266,000
-14,000
| -5% | -$151K |
|
|
CPHD
70
DELISTED
Cepheid Inc
CPHD
| $2.74M | 0.41% |
75,000
+24,000
| +47% | +$877K |
|
|
ARIA
71
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $2.69M | 0.41% |
430,000
| – | – |
|
72
Pacira BioSciences
PCRX
$1.22B
| $2.69M | 0.41% |
+35,000
| New | +$2.69M |
|
|
TSRO
73
DELISTED
TESARO, Inc.
TSRO
| $2.66M | 0.4% |
50,899
| – | – |
|
74
Xencor
XNCR
$594M
| $2.65M | 0.4% |
181,303
| – | – |
|
75
Exelixis
EXEL
$9.95B
| $2.59M | 0.39% |
+460,000
| New | +$2.59M |
|